FDA Approved: POSACONAZOLE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for posaconazole delayed-release (POSACONAZOLE DELAYED-RELEASE) from Chartwell RX, LLC, updating its labeling/approval f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidiasis
• Esophageal Candidiasis
• Invasive Aspergillosis
• Invasive Fungal Infection
• Mucormycosis
• Oropharyngeal Candidiasis

Drugs mentioned

• POSACONAZOLE (POSACONAZOLE)

Snippet

SUPPL AP for POSACONAZOLE (POSACONAZOLE DELAYED-RELEASE)